Keywords: glycodesign, gets, fda, approval, gd0039, trials, received

GLYCODesign gets FDA approval for GD0039 trials

Article | 23 February 1999

Print This

- GLYCODesign has received approval from the US Food and DrugAdministration to test its lead compound GD0039 in a Phase I/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in